Successive age groups, chronic diseases, priority professions: who can be vaccinated in France against Covid-19? In a vaccination center or in the city? And on what dates will other audiences have access?
– 60 years and over
All people in this age group can be vaccinated, in a vaccination center or in town, regardless of where they live and their state of health.
60% of this population category has already received at least one dose.
– 55-59 year olds
Anyone in this age group can be vaccinated in town (by a doctor, pharmacist or nurse), with AstraZeneca or Janssen vaccines.
People at very high risk of having a severe form of Covid are eligible for Pfizer / BioNTech and Moderna vaccines at a vaccination center. These are mainly cancer patients undergoing treatment, dialysis patients, organ or stem cell transplant recipients and people with Down’s syndrome.
Time slots in vaccination centers are also reserved for 55-59 year olds who are very exposed to Covid-19 by their profession: teachers, childcare professionals, police officers, gendarmes and prison supervisors since April 17, bus drivers, truck drivers, cashiers , employees of funeral directors and slaughterhouses, maintenance agents, employees of waste sorting centers, garbage collectors and transport and commercial security agents since April 24.
Air transport flight personnel will be added to this list, the Ministry of Transport said on Friday.
– 50-55 year olds
Under 55 years of age, only Pfizer and Moderna vaccines can be used, AstraZeneca and Janssen are not recommended due to a rare risk of serious side effects.
However, the Minister of Health Olivier Véran announced on Friday that he had seized the High Authority of Health (HAS) to study the possibility of allowing all volunteers, regardless of their age, to be vaccinated with AstraZeneca by signing a waiver of responsibility.
Between the ages of 50 and 55, currently only people affected by high-risk pathologies or certain chronic illnesses (also called co-morbidities) can be vaccinated.
These are mainly cardiovascular diseases (complicated arterial hypertension, history of stroke or heart surgery, heart failure), diabetes, respiratory diseases (respiratory failure, severe asthma, pulmonary fibrosis, sleep apnea, bronchial tubes). obstructive pulmonary disease) and cancers.
Chronic kidney and liver disease, immunosuppressed, obese or psychiatric disorders, dementia and neurological pathologies (multiple sclerosis, Parkinson’s disease, etc.) are also included.
Without age criteria, are added to this list health and medico-social professionals, disabled people in specialized accommodation and, since Monday, relatives of immunocompromised people.
This will also be the case in a few days for flight attendants likely to fly to countries with worrying variants.
French people aged 50 to 55 who do not belong to these categories still have to wait two weeks: the vaccination will be open to them on May 15.
– 18-49 year olds
They do not yet have access to vaccination, except in certain specific cases: high-risk pathologies, relatives of immunocompromised people and pregnant women from the second trimester of pregnancy.
A first enlargement will take place this weekend, with the opening to all adults with comorbidities that previously allowed vaccination for 50-54 year olds. Or “some 4 million French”, according to the Minister of Health.
The government also announced Friday that all over 18s could now be vaccinated in certain overseas territories (including Guadeloupe, Martinique and Guyana) and even from the age of 16 in Mayotte, the youngest department of France. France.
To all the others, Emmanuel Macron gave Friday “an appointment on June 15 to (get) vaccinated”.
– Under 18s
No official announcement has yet been made regarding the vaccination of minors.
The president of the strategic orientation council of vaccination, Alain Fischer, has estimated on several occasions that it would undoubtedly be necessary to vaccinate children to reach the threshold of 75% of the total vaccinated population allowing to hope for a group immunity.
Clinical trials are underway to verify the safety and effectiveness of vaccines in children and adolescents.
Moderna benefits from an authorization from the age of 16 in the European Union against 18 for Pfizer and BioNTech, but the latter announced on Friday that it had requested authorization for its vaccine for 12-15 year olds.